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Abstract  1 
Background: Current guidelines for perioperative management of COVID-19 are 2 
mainly based on extrapolated evidence or expert opinion. We aimed to 3 
systematically investigate how COVID-19 affects perioperative management and 4 
clinical outcomes, to develop evidence-base guidelines.       5 
Methods: First, we conducted a rapid literature review in Embase, Medline, PubMed, 6 
Scopus, and Web of Science (1st January to 1st July 2020), using a predefined protocol. 7 
Secondly, we performed a retrospective cohort analysis of 166 women undergoing 8 
Caesarean section at Tongji Hospital, Wuhan during the COVID-19 pandemic. 9 
Demographic, imaging, laboratory, and clinical data were obtained from electronic 10 
medical records.     11 
Results: The review identified 26 studies, mainly case reports/series. One large 12 
cohort reported greater mortality in elective surgery patients diagnosed after, rather 13 
than before surgery. Higher 30-day mortality was associated with emergency surgery, 14 
major surgery, poorer preoperative condition and surgery for malignancy. Regional 15 
anaesthesia was favoured in most studies and personal protective equipment (PPE) 16 
was generally used by healthcare workers (HCW), but its use was poorly described 17 
for patients. In the retrospective cohort study, duration of surgery, oxygen therapy 18 
and hospital stay were longer in suspected or confirmed patients than negative 19 
patients, but there were no differences in neonatal outcomes. None of the 262 20 
participating HCWs was infected with SARS-CoV-2 when using level 3 PPE 21 
perioperatively.     22 
Conclusions: When COVID-19 is suspected, testing should be considered before 23 
non-urgent surgery. Until further evidence is available, HCWs should use level 3 PPE 24 
perioperatively for suspected or confirmed patients, but research is needed on its 25 
timing and specifications. Further research must examine longer-term outcomes.     26 
Registration: The rapid review was registered in PROSPERO (ID: CRD42020182891). 27 
Keywords: Coronavirus, COVID-19, SARS-CoV-2, perioperative, Caesarean section, 28 
rapid review 29 































































   
Introduction 1 
Coronavirus disease 2019 (COVID-19), resulting from the severe acute respiratory 2 
syndrome coronavirus 2 (SARS-CoV-2) virus, has become a global pandemic since it 3 
was first described in Wuhan, China in December 20191, and was declared a public 4 
health emergency. As of 10th August 2020, over 19 million cases and over 728,000 5 
deaths have been reported worldwide2. In the UK alone, 310,829 cases have been 6 
reported with 46,574 deaths, and in China there have been 89,270 cases and 4,693 7 
deaths2. In response to this health crisis, guidelines have been published on the 8 
clinical management of patients undergoing surgery to prevent transmission to 9 
healthcare workers (HCW) and adverse outcomes in patients3, 4. However these are 10 
mainly based on pre-existing practices rather than on data from patients with 11 
suspected or confirmed COVID-19, and little is known about how perioperative 12 
techniques affect transmission rates and outcomes in patients with COVID-19. 13 
Furthermore, a rapid review of clinical guidelines published early in the COVID-19 14 
pandemic concluded that their overall quality was low and their focus should be on 15 
evidence-based recommendations, rather than consensus5. This study therefore had 16 
2 objectives: 17 
I. To conduct a rapid review of studies and case reports examining the 18 
management of patients with suspected or confirmed COVID-19 undergoing 19 
surgery, and subsequent morbidity, mortality, length of hospital stay, use of 20 
intensive care, respiratory and pain support, and COVID-19 transmission to 21 
HCWs.  22 
II. To examine perioperative approaches and outcomes in a series of Caesarean 23 
section operations undertaken in Tongji Hospital, Wuhan, during the 24 




































































   
Methods 1 
I. Rapid Review 2 
The reporting of this review followed the Preferred Reporting Items for Systematic 3 
Reviews and Meta-Analyses (PRISMA) guidelines6. Due to the fast-evolving nature of 4 
COVID-19 and the need to produce clinical evidence for making recommendations on 5 
patient care that are readily available to HCWs in a timely manner, we chose to adopt 6 
a rapid approach to the review7. This involved a streamlined protocol whereby article 7 
identification, appraisal and data extraction were shared between two reviewers, 8 
with some overlap for quality control, instead of complete independent duplication. 9 
Details of the protocol were registered on PROSPERO: International prospective 10 
register of systematic reviews (ID: CRD42020182891) and can be accessed at 11 
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=182891. 12 
 13 
Eligibility Criteria 14 
Population: Any patient undergoing surgery who had confirmed or suspected 15 
COVID-19 at the time of surgery.  16 
Intervention: Any form of surgery and perioperative management undertaken whilst 17 
the participant was suspected or confirmed as having COVID-19, except where the 18 
procedure was conducted to treat COVID-19. Any studies not reporting details of 19 
patient management at any time during the perioperative period (defined as 24 20 
hours before and after surgery) were excluded from the review. Studies were also 21 
excluded if they included patients who did not undergo surgery, and where it was not 22 
possible to identify them separately from surgical patients.  23 
Comparator: Where relevant, patients with suspected or confirmed COVID-19 who 24 
were not subject to perioperative interventions. 25 
Outcomes: Patient, HCW and neonatal postoperative outcomes, where relevant. 26 
Study type: Observational studies including cross-sectional, case-control and cohort 27 
designs as well as case-series or case-reports and randomized control trials (RCTs) 28 
could be included. As the database search, article screening and data extraction 29 































































   
processes were conducted by UK-based authors, only English language articles were 1 
considered, to avoid misinterpretation of the data. Unpublished studies, conference 2 
abstracts and research theses or dissertations were also excluded (Table 1).  3 
We searched PubMed, MEDLINE, EMBASE, Scopus, and Web of Science for original 4 
articles, reported in English. Databases were searched from 1st January 2020, with 5 
initial search to 4th May 2020; the search was updated on 1st July 2020. As the 6 
purpose of this study is to provide both clinical evidence and recommendations for 7 
further research in a timely manner, it was decided to exclude studies with a sample 8 
size of less than 15 in the rerun of search terms (4th May-1st July 2020). Such studies 9 
are likely to be dominated by lower quality case reports, which would not contribute 10 
substantially to the overall evidence presented in this study. In addition the reference 11 
sections of included studies were also checked for relevant studies.  12 
The search terms used for all 5 databases included words related to COVID-19 (the 13 
population), surgical interventions and perioperative management (the 14 
interventions). Comparator, outcomes and study type search terms were not used. 15 
Where available, the study year filter was set to 2020 (Supplementary Table S1).    16 
After retrieving articles from the databases, non-English language and duplicates 17 
were removed. HLH and LAC then independently screened the titles and abstracts 18 
according to the inclusion and exclusion criteria to identify relevant studies. 19 
Remaining articles then went through full-text review (HLH and LAC), noting reasons 20 
for all exclusions. Any differences in opinion were settled by discussion between the 21 
reviewers and, where necessary, the wider research team.  22 
 23 
Data Extraction 24 
A pro forma spreadsheet was constructed and data extraction was conducted 25 
independently by HLH and AC, who reviewed an equal number of studies with a 26 
6-study overlap for quality control. Any differences in data extraction for the 27 
overlapped studies were resolved between HLH and AC. Due to the rapid nature of 28 
the review, study authors were not contacted to resolve missing data or identify 29 































































   
further studies.  1 
The following data items were extracted: 2 
1. Study details – authors, journal of publication, date of publication, 3 
country/countries where the study took place, sample size and study design. 4 
2. Patient characteristics – age, gender, body mass index (BMI)/weight, 5 
comorbidities and method of diagnosing or suspecting COVID-19. 6 
3. Surgical details – type, schedule, indications, duration and other relevant 7 
details.  8 
4. Perioperative management – HCW use and level of personal protective 9 
equipment (PPE), patient use of PPE, patient time between symptoms and 10 
surgery, type of anaesthesia (e.g. general/regional), analgesics used, pain 11 
assessment, vasopressors used, blood loss and any other relevant details.   12 
5. Postoperative outcomes – HCW COVID-19 status, patient discharge status, 13 
length of hospital stay, use of intensive care unit (ICU) or high dependency 14 
unit (HDU), level of respiratory support, use of analgesia, mortality and, 15 
where relevant to the study, neonatal COVID-19 status, Apgar score, mortality, 16 
discharge status and any other relevant reported details  17 
 18 
Risk of Bias (Quality) Assessment 19 
The quality of reporting of all included studies was evaluated by HLH and AC 20 
according to the CAse REport (CARE) guidelines8 for case reports/series or the 21 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 22 
guidelines9 for cross-sectional, case-control and cohort studies. A quality score10, 11 23 
was calculated for each article based on a checklist of 36 items for CARE 24 
(Supplementary Table S2) and 32-34 items for STROBE (Supplementary Table S3), 25 
depending on the type of observational study. The presence of an item scored one, 26 
absence scored zero and the total was calculated. A percentage of the maximum 27 
possible score was also calculated and “high quality” was defined as any study 28 
achieving a score of 80% or greater10, 12. “Low quality” was defined as any study with 29 































































   
a score of less than 80%. Higher scores indicate studies with reporting of higher 1 
quality. Disagreements were resolved via discussion between the 2 reviewers. 2 
 3 
Summary Measures 4 
For case reports and series with sample size ≤5, numeric values are reported 5 
individually. Otherwise summary statistics are presented (e.g. median, mean, range, 6 
interquartile range [IQR] or standard deviation [SD]) as reported in original papers. 7 
Qualitative variables are reported as counts. A synthesis of the extracted data was 8 
constructed, structured around the type of surgery performed, surgical practices, 9 
population demographic and clinical characteristics, and type of outcome. 10 
Recommendations for the perioperative management of patients with COVID-19 11 
were developed from the synthesised evidence, and tables were constructed to aid 12 
the presentation of the extracted data and quality assessment of each article.  13 
 14 
II. Cohort Study 15 
Study design and data sources and ethics 16 
This single-centre, retrospective study was approved by the Institutional Review 17 
Board of Tongji hospital, Tongji Medical College, Huazhong University of Science and 18 
Technology (TJ-IRB20200421). The requirement for informed consent from 19 
participants was waived under the regulations of the Institutional Review Board. 20 
Data, including demographic, clinical, imaging, laboratory, perioperative 21 
management, and maternal and fetal outcomes, were extracted from the electronic 22 
database of medical records at Tongji Hospital, and anonymised for analyses.  23 
Data from all parturients who underwent Caesarean section (including emergency 24 
surgery) during the COVID-19 pandemic in Wuhan were included in this study. In 25 
order to ensure completeness of reported data, we included all patients who had 26 
undergone Caesarean section in the defined time period. Part of this data has been 27 
reported previously by other groups 13, 14. COVID-19 case definitions were based on 28 































































   
the National Health Commission of China’s diagnostic criteria (seventh edition) (Box 1 
1)15. A confirmed case of COVID-19 was defined as a suspected case with a positive 2 
result of real-time reverse transcriptase–polymerase chain reaction (RT-PCR) assay of 3 
respiratory tract specimens or serum-specific antibodies to SARS-CoV-2. If the results 4 
of 2 RT-PCR tests taken at least 24-hour apart, and serum-specific antibodies to 5 
SARS-CoV-2 detected at least 7 days after the onset of the disease, were negative in a 6 
suspected case, the diagnosis of COVID-19 was excluded. All patients were tested 7 
with RT-PCR or antibodies or CT when possible. If COVID-19 was suspected or 8 
confirmed, follow-up tests were performed after surgery. 9 
 10 
Perioperative management  11 
Before entering the operating room, triage was performed by obstetricians and 12 
anaesthetists, including medical history review, brief physical examination, and 13 
reviewing blood test results, chest computed tomography (CT), test for nucleic acid 14 
of SARS-CoV-2 or SARS-CoV-2 antibodies. Because individuals might be infected with 15 
SARS-CoV-2 but be asymptomatic, all patients were placed in an isolation holding 16 
area and transferred to a dedicated negative pressure system operating room with an 17 
anteroom beside it (buffer area). The patients wore surgical or N95 masks 18 
throughout the process. After the patient entered the operating room, routine 19 
monitoring including continuous electrocardiograph, regular non-invasive blood 20 
pressure, and peripheral pulse oximetry were performed. Spinal anaesthesia or 21 
combined spinal epidural anaesthesia was the primary choice. General anaesthesia 22 
with tracheal intubation was an option under certain circumstances such as 23 
contraindications of spinal anaesthesia, maternal or fetal emergencies, or failed 24 
spinal anaesthesia. During the intubation, surgeons and nurses remained in the 25 
operating room, to ensure that surgery started as soon as possible after induction. 26 
The neonatal team was notified before delivery, in order to attend and make any 27 
necessary preparations. After delivery, the newborns were cleaned immediately to 28 
remove blood clots, meconium and amniotic fluid. The newborns were then placed 29 































































   
under a radiant warmer in a cordoned-off area in the operating room. The Apgar 1 
scores of newborns were assessed at 1 and 5 minutes. For patients with suspected or 2 
confirmed COVID-19, their newborns were transferred to a neonatology isolation 3 
room shortly after delivery. SARS-CoV-2 nucleic acid tests were then carried out as 4 
soon as possible in all newborns. Maternal contact was not allowed. One day after 5 
surgery, full blood count and coagulation tests were performed in parturients. If 6 
COVID-19 was suspected or confirmed, chest CT, nucleic acid of SARS-CoV-2 or 7 
SARS-CoV-2 antibodies were tested again. Body temperatures or any other symptoms 8 
associated with COVID-19 were recorded daily by nurses, throughout the hospital 9 
stay. According to the parturients' clinical condition, supplemental oxygen was 10 
delivered via nasal cannula or mask to maintain an SpO2 of 95% and above. Other 11 
methods of non-invasive or invasive ventilation were considered if necessary. 12 
Diclofenac and/or dezocine was given, as requested by the parturients, to relieve 13 
postoperative pain. 14 
 15 
Perioperative protection and postoperative evaluation of healthcare workers 16 
Self-protection precautions were strictly followed by all participating HCWs. Level 3 17 
PPE including N95 mask, fluid-resistant gown, goggle, face shield, disposable hair 18 
cover, head covering, 2 layers of gloves, and fluid-resistant shoe covers, was used by 19 
all HCWs involved. PPE was donned before entering the operating room and was 20 
doffed after exiting operating room in buffer area. All HCWs involved had a 24-hour 21 
duty shift every one to two weeks. They were required to report any COVID-19 22 
related symptoms such as fever, cough or fatigue. At the beginning of April, 2020, all 23 
HCWs were required to have a SARS-CoV-2 antibodies detection test, a test for 24 
nucleic acid of SARS-CoV-2 on nasopharyngeal swabs and a chest CT scan. 25 
 26 
Statistical analysis 27 
Suspected or confirmed cases were categorised together and compared with 28 
negative cases. Maternal outcomes including duration of operation, oxygen therapy 29 































































   
and hospital stay, and fetal outcomes such as Apgar scores at 1 minute and 5 minutes 1 
were compared between groups. Continuous variables are presented as median 2 
(IQR). These data failed the Shapiro-Wilk test for normality and significance was 3 
calculated using Mann-Whitney U tests. Categorical variables are expressed as 4 
number (%) and analysed using chi-square tests. SPSS 21.0 statistical software (SPSS, 5 
Inc. Chicago, IL, USA) was used for all statistical analyses. A 2-sided P-value <0.05 was 6 
considered to be statistically significant.7 































































   
Results 1 
I. Rapid Review 2 
Study Selection 3 
The workflow for identifying and screening articles is provided in figure 1. The initial 4 
literature searches yielded 3,227 papers. The re-run of the search yielded a further 5 
107 articles. After removal of duplicates, non-English language papers and title and 6 
abstract screening, 64 articles remained for full-text review. Articles identified during 7 
the re-run of search terms (from 4th May to 1st July, 2020) that were excluded on the 8 
basis of having a sample size ≤15 are shown in Supplementary Table S4. A full list of 9 
the 38 articles excluded on full-text review, with reasons, is provided in 10 
Supplementary Table S5. We therefore identified 26 articles for inclusion in this 11 
review16-41. 12 
 13 
Study Characteristics 14 
The characteristics of each included study ar  summarized in Table 2. There were no 15 
RCTs. Twenty-two of the papers were lower quality case reports or case series16, 17, 19, 16 
21-32, 34-39, 41. The remaining 4 were observational studies, of which 2 were cohort 17 
studies20, 33, 1 was a small cross-sectional study (n=7)18 and 1 was a retrospective 18 
4-centre clinical study (n=37)40. The cross-sectional study was published without 19 
peer-review18. Only one study met our definition of “high quality”33. 20 
Sixteen of the studies were conducted in China, where the virus was first reported19, 21 
21, 22, 25, 27, 29, 30, 32, 34-41. Three were conducted in Italy18, whilst 1 study was conducted 22 
in each of Iran18, Peru16, Portugal31, Republic of Korea28, Sweden26 and USA24. One 23 
paper was a multi-centre cohort study conducted in 24 different countries, led by a 24 
centre in the UK33.  25 
 26 
Risk of Bias (Quality) Assessment 27 
CARE Quality assessment scores ranged from 7 to 26 (out of 36) for the case reports 28 































































   
and case series STROBE scores ranged from 10 to 33 (out of 34) for the observational 1 
studies (Table 2). A full breakdown of scores for each study is provided in 2 
Supplementary Tables S6 and S7. 3 
Due to the limited sample sizes of the included studies, the heterogeneity in 4 
surgeries performed and approaches to perioperative management, and the inherent 5 
lack of comparative groups in the case reports, it was not possible to conduct a 6 
meta-analysis to estimate effect sizes and we could not quantitatively assess risk of 7 
bias across studies.       8 
 9 
COVID-19 status 10 
Diagnosis of COVID-19, and timing of diagnosis (relative to surgical procedure) were 11 
variably reported, applying a range of diagnostic criteria. Suspected COVID-19 was 12 
usually based on relevant symptoms. All of the studies used RT-PCR for SARS-CoV-2 13 
RNA or chest CT scans for diagnosis (though 1 study did not report diagnostic 14 
criteria32). Four studies used RT-PCR only26, 29, 31, 35, 2 studies used CT scans18, 27 only 15 
and 19 studies used a combination of both16, 17, 19-25, 28, 30, 33-41. In some places RT-PCR 16 
was not available33. Specimens used for RT-PCR included nasopharyngeal, 17 
oropharyngeal, sputum, tracheal tube tip and bronchoalveolar lavage. Although not 18 
fully reported in all studies, RT-PCR tests were negative in some cases despite CT 19 
findings (and in some cases, symptoms) being indicative of COVID-1925, 41.  20 
 21 
Perioperative management 22 
The total number of surgical procedures reported in the included studies was 1,370, 23 
including gastrointestinal/abdominal (n=393)18, 20, 25, 33, 40, orthopaedic (n=352)17, 18, 20, 24 
33, 40, 41, obstetric/gynaecological (n=166)16, 19, 21-23, 26, 28-31, 33-41, 25 
cardiothoracic/vascular (n=146)20, 24, 27, 33, 40, hepatobiliary (n=62)33, neurosurgical 26 
(n=47)20, 33, 40, head and neck (n=40)33, urological (n=37)33, other surgeries (n=63)33, 40 27 
and missing details (n=64)32, 33. The schedule of the surgeries, where reported, were 28 
classed as elective (n=316), and urgent, or emergency (n=949). At least 153/166 of 29 































































   
the obstetric/gynaecological surgeries were Caesarean sections. Most of the other 1 
surgeries were for cancer or trauma (Supplementary Table S8).  2 
Most studies reported surgical procedures performed under neuraxial anaesthesia 3 
(Table 3). Ten reported procedures (53 Caesarean sections, 17 orthopaedic) using 4 
neuraxial anaesthesia only17, 22, 26, 28, 30, 31, 34, 36, 37, 41 and 3 reported procedures (5 5 
aortic dissections and 1 Caesarean section) using general anaesthesia only16, 24, 27, 6 
whilst 6 reported a mix of surgeries performed using either general or neuraxial 7 
anaesthesia19, 20, 32, 33, 35, 40. When reported, spinal, epidural or a combination of the 2 8 
methods were used. Exact details of which anaesthetics and analgesics were used 9 
were only reported in 5 of the 26 studies19, 28, 34, 37, 41. It is not clear whether there 10 
were any changes from standard anaesthetic/analgesic practice because of 11 
COVID-19.  12 
 13 
Use of Personal Protective Equipment (PPE) and infection reduction strategies 14 
Patient use of PPE was poorly reported, with only 9 studies stating that patients wore 15 
any protection19, 21-23, 28, 29, 35, 38, 39. Six of these reported the use of surgical masks 16 
only19, 21, 22, 28, 35, 38, with N95 masks being more specifically mentioned in 3 studies21, 17 
22, 28.  18 
HCW use of PPE was more comprehensively reported, with 16 studies describing its 19 
perioperative use19, 22-31, 35-38, 41. The reported type of PPE used by HCWs was 20 
wide-ranging with N95 mask, disposable surgical cap, medical goggles or 21 
positive-pressure headgear, and disposable protective clothing, gloves and 22 
shoes/shoe covers described. However, details on duration of PPE use, and at what 23 
points during the perioperative period (e.g. only during intubation/aerosol 24 
generating procedures) were lacking.  25 
Nine of the studies in our review reported using operating rooms with negative 26 
pressure19, 21, 22, 24, 28, 29, 35, 36, 38. Only 1 of these studies also described the 27 
postoperative care of a patient in a negative pressure ICU24, although 2 studies 28 
described sending neonates to negative-pressure wards immediately after birth29, 31. 29 































































   
However details on other elements of ventilation such as air changes per hour, 1 
direction and filtration were lacking.  2 
Twelve of the studies describing Caesarean sections reported immediate separation 3 
of the neonates from their mothers following delivery, aiming to reduce risks of 4 
postpartum infection. Eight of these were conducted in China19, 21, 30, 34-36, 38, 39, while 5 
the other 4 were conducted in Italy23, Portugal31, Peru16, and the Republic of Korea28. 6 
Three studies reported on the decontamination of the anaesthesia machine 7 
following surgery19, 24, 40, with two of the studies reporting no HCW infection with 8 
COVID-1919, 24 (the third study did not report HCW COVID-19 status40). A further 9 
study reported the discarding of disposable anaesthetic devices after single use27.     10 
 11 
Patient outcomes 12 
Patient outcomes reported included length of hospital stay, requirement for critical 13 
care, level of respiratory support and respiratory complications, discharge status, and 14 
mortality (Supplementary Table S9). None of the included studies reported on all 15 
these outcomes. Reporting on discharge status was very limited. Twelve studies 16 
reported length of stay in hospital, which ranged from 5 to 52 days18-20, 22, 25, 26, 28-31, 33, 17 
35. 18 
In the largest cohort study (n=1,128), the median length of stay in hospital (IQR) was 19 
10 days (3-27) for minor surgery and 17 days (8-29) for major surgery, reported in a 20 
total of 1,083 patients33. This study reported an overall 30-day mortality of 23.8%, 21 
with a higher rate of mortality in patients undergoing elective surgery where the 22 
presence of SARS-CoV-2 virus had been confirmed postoperatively rather than 23 
preoperatively (20.4% vs 9.1%). A number of patient factors were found to be 24 
associated with higher 30-day mortality including male sex (odds ratio [OR] = 1.75, 95% 25 
confidence interval [CI] = 1.28-1.40), emergency surgery (OR = 1.67, 95% CI = 26 
1.06-2.63), major surgery (OR = 1.52, 95% CI = 1.01-2.31), older age (>70 years) (OR = 27 
2.30, 95% CI = 1.65-3.22), poorer preoperative condition as assessed by American 28 
Society of Anesthesiologists’ physical status classification (OR = 2.35, 95% CI = 29 































































   
1.57-3.53) and undergoing surgery for malignancy (OR = 1.55, 95% CI = 1.01-2.39). 1 
Pulmonary complications, defined as pneumonia, acute respiratory distress 2 
syndrome or unexpected postoperative ventilation, occurred in 51.2% of patients 3 
with COVID-19, and was associated with increased mortality compared to those who 4 
did not develop complications (38.0% vs 8.7%).  5 
Postoperative use of ICU was poorly reported and where it was reported (9 studies)18, 6 
20, 22-25, 27, 32, 33, it was not always clear whether the patients had been transferred 7 
there due to COVID-19, or whether they would have been transferred there anyway 8 
because of the indication for surgery27. Postoperative respiratory support was 9 
described in 10 studies17, 18, 20, 23, 24, 26, 27, 31, 33, 37, but as with ICU use it was not clear in 10 
some papers whether this would have occurred anyway. Postoperative use of 11 
analgesia was only reported in 3 studies17, 28, 37, with only 1 reporting any formal pain 12 
assessment19.  13 
Reporting of outcomes in neonates was more consistent, with 16 studies (out of 19 14 
studies involving obstetric surgeries) reporting COVID-19 status16, 19, 21-23, 26, 28-31, 34-39 15 
and 12 of those studies reporting only negative test results, mainly for RT-PCR19, 21, 22, 16 
26, 28-31, 34-38. Of the other 4 studies, 2 reported only positive tests23, 39 and 2 reported 17 
a mix of positive and negative results16, 35. Apgar scores were reported in 14 studies 18 
(of the 19 involving obstetric surgeries), and these were generally very good or 19 
excellent16, 19, 21-23, 26, 28, 30, 31, 34-38. No neonatal mortalities were reported in any of the 20 
studies.  21 
 22 
Healthcare worker outcomes 23 
Most of the studies reported outcomes within a few days to 2 weeks after surgery. 24 
HCW COVID-19 outcomes were only reported in 10 studies19, 22-24, 28, 30, 32, 35, 37, 41. One 25 
of these, a case series of 49 patients including outcomes from 44 anaesthetists, 26 
reported 5 anaesthetists testing positive for SARS-CoV-2 on RT-PCR testing, following 27 
delivery of spinal anaesthesia during Caesarean section or orthopaedic surgery41. 28 
One of the 5 anaesthetists testing positive for SARS-CoV-2 had worn level 3 PPE (2.7% 29 































































   
of all who wore level 3 PPE), while 4 of them had worn level 1 PPE (57.1% of all who 1 
wore level 1 PPE), suggesting better HCW protection with level 3 PPE. This also 2 
appears to be supported by 8 of the other 9 studies where no HCW SARS-CoV-2 3 
infections were reported when using PPE19, 22-24, 28, 30, 35, 37. Three of these studies 4 
reported level 3 PPE22, 30, 37, 1 reported biosafety level 319 and 4 studies described 5 
PPE in detail including N95 mask, eye goggles, face shield and surgical gown23, 24, 28, 35. 6 
However we can only make tentative recommendations on the use of PPE as it was 7 
not clearly reported how long the PPE was worn before, during and/or after the 8 
surgery and whether any changes were made to the level of PPE worn at any stage 9 
(for example following intubation/extubation of the patient). Furthermore, we 10 
cannot be sure that HCW infection occurred as a result of caring for patients with 11 
COVID-19 rather than other sources such as infected colleagues or in the wider 12 
community41.   13 
 14 
II. Cohort Study 15 
Patient characteristics 16 
Between 23rd January 2020 and 31st March 2020, 166 parturients underwent 17 
Caesarean section and were included in this study. Before surgery, 2 patients were 18 
confirmed to be infected with SARS-CoV-2 and 36 patients were considered as 19 
suspected cases based on the above criteria (Box 1). After surgery, 5 suspected cases 20 
were confirmed and 11 suspected cases were ruled out. Finally, 7 confirmed cases 21 
and 20 suspected cases of COVID-19 were identified. One case report14 and 5 22 
patients (patient 1, 4, 5, 6 and 7) from a case series13 were reported previously by 23 
others. The other 2 patients (patient 2 and 3) in the case series13 undergoing 24 
caesarean section between 1st January, 2020 and 23rd January, 2020 were not 25 
included in the current study. All 20 suspected cases had imaging features of 26 
COVID-19. They were tested with RT-PCR only before discharge and the results were 27 
negative. For analysis, we combined these suspected cases and confirmed cases as 1 28 
group (n=27) and patients not (suspected to be) infected with COVID-19 as a second 29 































































   
‘negative’ group (n=139). As shown in Supplementary Table 10, the BMI of suspected 1 
or confirmed patients was higher than that of negative patients (P = 2 
0.034). Symptoms associated with COVID-19 occurred only in suspected or confirmed 3 
patients; fever was the commonest with an incidence of 44.4%, followed by cough 4 
(14.8%) and diarrhoea (3.7%). 5 
Laboratory findings of patients before and after Caesarean section are summarised in 6 
Supplementary Table 11. Compared with baseline pre-procedural values, increased 7 
leukocyte and neutrophil counts were observed after surgery in all patients. 8 
Compared with negative patients, suspected or confirmed patients had lower 9 
leukocyte (P = 0.003 before surgery; P = 0.047 after surgery) and lymphocyte (P = 10 
0.030 before surgery; P = 0.041 after surgery) counts during the perioperative period. 11 
Baseline preprocedural C-reactive protein levels in confirmed or suspected patients 12 
were higher than negative patients (P = 0.014), but were not difference from 13 
postsurgical levels. In negative patients, there were significantly elevated levels of 14 
CRP (P = 0.006) and D-dimer (P = 0.011) after surgery compared with baseline 15 
preprocedural values. 16 
 17 
Characteristics of anaesthesia and surgery 18 
An overview of parturients’ intraoperative characteristics is shown in Supplementary 19 
Table 10. Regional anaesthesia was the commonest type of anaesthesia and was 20 
performed in 142 (85.5%). Duration of operation in suspected or confirmed patients 21 
was longer than that in negative patients (P = 0.003). However, there were no 22 
significant differences in blood loss, fluid management, or use of vasoactive drugs 23 
and flurbiprofen. 24 
 25 
Maternal and fetal outcomes 26 
As listed in Supplementary Table 10, 48.8% of patients received diclofenac and/or 27 
dezocine for postoperative pain. There was no significant difference between 28 
suspected or confirmed patients and negative patients. Both the duration of oxygen 29 































































   
therapy (P < 0.001) and length of hospital stay (P < 0.001) were significantly longer in 1 
suspected or confirmed patients than negative patients. No suspected or confirmed 2 
patients developed severe pneumonia or received non-invasive or invasive 3 
mechanical ventilation. However, a negative patient with liver cancer was intubated 4 
and died due to pulmonary embolism after surgery. 5 
The medians of Apgar scores were 8 at 1 minute and 9 at 5 minutes. There were no 6 
apparent differences in the neonates when comparing the suspected or confirmed 7 
group with the negative group. In the negative group, a neonate delivered at 25 8 
weeks' gestation died 10 min after birth. In the confirmed group, a neonatal 9 
COVID-19 infection with positive results of RT-PCR assay on pharyngeal swabs was 10 
reported 36 hours after birth, and this had been reported in a previous study13. 11 
However, the results of nucleic acid tests for SARS-CoV-2 on placenta specimens, 12 
cord blood and mother’s breast milk in this mother–neonate dyad were all negative. 13 
 14 
Postoperative evaluation of healthcare workers 15 
A total of 262 HCWs including 71 anaesthetists, 60 obstetricians and 131 nurses 16 
(circulating nurses, instrument nurses and neonatal nurses) were involved in these 17 
Caesarean sections. Level 3 PPE was used by all the HCWs during the operation. 18 
None of them reported COVID-19 related symptoms during the COVID-19 pandemic. 19 
As of 15th April, 2020, none of them has been infected with the SARS-CoV-2 20 
according to the CT scan findings, RT-PCR testing and/or SARS-CoV-2 antibodies 21 
testing. 22 































































   
Discussion 1 
Our rapid literature review identified 26 studies reporting perioperative management 2 
of patients with suspected or confirmed COVID-19. To our knowledge this is the most 3 
comprehensive such review to date. Most studies were low quality case 4 
reports/series with low sample size, and even amongst the observational studies, 5 
perioperative management was not necessarily the main focus of any quantitative 6 
analysis conducted20, 33 and was poorly reported18. Thus, a cohort study of Caesarean 7 
sections, especially focusing on perioperative management and patients and HCW 8 
outcomes, was performed to augment the included evidence base. 9 
All studies included in the review used either RT-PCR or CT scans to diagnose 10 
SARS-CoV-2/COVID-19. This approach appears to be supported by the fact that 11 
RT-PCR testing did not always produce positive results, despite the presence of 12 
relevant clinical symptoms and the elimination of other viruses or comorbidities that 13 
could potentially explain those symptoms. In our cohort study, only 5 out of 27 14 
participants with suspected or confirmed COVID-19 were positive for SARS-CoV-2 by 15 
RT-PCR. The wider literature has also reported uncertainty in diagnostic performance 16 
of RT-PCR42 and when compared to CT scans their sensitivity ranges from 50-81%43-45. 17 
The use of CT scans does need to be balanced against the extra risk of exposing 18 
patients to radiation, particularly for women undergoing Caesarean section whose 19 
fetus will also be exposed46. This is an area that requires further investigation, but 20 
consideration should be given to using both approaches in diagnosing COVID-19.  21 
The timing of COVID-19 testing also needs to be considered since higher mortality 22 
was reported in patients undergoing elective surgery where the presence of 23 
SARS-CoV-2 virus has been confirmed postoperatively rather than preoperatively 24 
(20.4% vs 9.1%)33. Performing tests preoperatively will enable informed decisions 25 
about the postponement of surgeries to be made for patients who test positive and 26 
are thus at increased risk of postoperative complications. There may also be 27 
requirements to ensure appropriate levels of care, such as facilities or staffing, are 28 































































   
available for the postoperative period should complications arise. COVID-19 testing 1 
may also influence ICU admissions and transmission to HCWs47-49. This further 2 
suggests that testing for possible SARS-CoV-2 infection should take place before 3 
surgery, as supported by The American Society of Anesthesiologists and Anesthesia 4 
Patient Safety Foundation joint guidelines50. However this might be difficult for 5 
emergency surgery, therefore a standardised diagnosis and treatment protocol for 6 
emergency patients should be developed. This is already happening in some places 7 
and whilst pre-operative screening will potentially increase the time between 8 
admission and surgery, initial evidence suggests that this risk can be minimised to the 9 
point that it can be balanced against the potential risk of performing surgical 10 
procedures in COVID-19 patients51. Further research is needed to establish whether 11 
the testing pathway is of more clinical benefit than not having it. In patients with 12 
suspected or confirmed COVID-19, the COVID-19 status of newborns should also be 13 
taken into account where relevant, and testing should be performed as soon as 14 
possible after delivery to help prevent transmission to HCWs and to ensure risk to 15 
the newborn is minimised, with early recognition and management of symptoms.  16 
Despite being included in perioperative anaesthesiology guidelines for HCWs in both 17 
America and China3, 50, PPE use was poorly reported by studies in patients (9 18 
studies)19, 21-23, 28, 29, 35, 38, 39. Current guidance in the UK is that anyone with suspected 19 
or confirmed COVID-19 should wear a surgical face mask in clinical areas, communal 20 
waiting areas and during transportation as long as this does not compromise their 21 
clinical care52. In tuberculosis patients, the use of surgical facemasks has been shown 22 
to confer a 56% decreased risk of transmission compared to those not wearing a 23 
mask53. Furthermore, a literature review of studies analysing the effectiveness of 24 
respiratory protection for healthcare workers against infectious diseases found that 25 
guidelines were consistent in recommending at least an N95 respirator for care of 26 
patients with tuberculosis54. Despite this, there is currently no evidence that patient 27 
use of face masks reduces risk of COVID-19 transmission to HCWs, despite these 28 
studies not reporting any HCW infections19, 21-23, 28, 29, 35, 38, 39. Better reporting was 29 































































   
observed relating to HCWs themselves. A recent study has demonstrated the 1 
effectiveness of HCWs wearing PPE in preventing COVID-19 infection and advocated 2 
its continued use in the absence of a vaccine55. In our cohort study, none of the 262 3 
HCWs developed COVID-19, suggesting that both regional and general anaesthesia 4 
can be delivered safely to patients with COVID-19, when surgical or N95 masks are 5 
applied in patients and level 3 PPE is used by HCWs during the perioperative period. 6 
The use of aprons, sterile fluid resistant disposable gown, sterile gloves, fluid 7 
resistant surgical masks and eye protection is recommended in the UK for Caesarean 8 
sections56. However, high level PPE is difficult to work in. For this reason it is 9 
important that future studies report on the duration of PPE use, whether they were 10 
used at particular points in the surgical process as some procedures are considered 11 
particularly high risk of airborne transmission and what levels constitute safe use57. It 12 
is also important to establish when PPE use is not necessary, to prevent wastage. 13 
Until these questions are addressed, HCWs should continue to use level 3 PPE during 14 
the perioperative period for all untested, suspected or confirmed cases of COVID-19 15 
during times of pandemic and local outbreak55.  16 
Although this was not analysed directly with respect to postoperative outcomes, we 17 
found that 9 of the studies reported conducting surgical procedures in negative 18 
pressure operating rooms19, 21, 22, 24, 28, 29, 35, 36, 38. Negative pressure rooms are 19 
commonly used in infection control and ensure that air continually flows into the 20 
room, rather than the surrounding area. However, most hospitals only have a limited 21 
number of negative pressure operating rooms and therefore have to adapt additional 22 
rooms for this purpose. As current recommendations on minimum environmental 23 
ventilation requirements are based on previous non-COVID-19 work, further analysis 24 
and reporting on ventilation characteristics is required3.    25 
We identified 12 studies reporting the separation of neonates from mothers 26 
following Caesarean section16, 19, 21, 23, 28, 30, 31, 34-36, 38, 39. In our cohort study, newborns 27 
of mothers with suspected or confirmed COVID-19 were also transferred to an 28 
isolated observation ward after birth. At least in China, where 9 of those studies were 29 































































   
conducted, this represents a significant change from standard practice where 1 
normally mother and child skin-to-skin contact is encouraged, with recognised 2 
neurobiological benefits for mother and neonate. Although a newborn whose 3 
mother was confirmed with COVID-19 tested positive 36 hours after birth in our 4 
cohort study, whether the case was a contact transmission or a vertical transmission 5 
remains to be confirmed. Since the remaining studies did not accurately report level 6 
of mother and child contact, it is not possible to determine whether separation 7 
decreases the risk of SARS-CoV-2 infection. Emerging data suggest that allowing 8 
neonates to room in with their mothers and breastfeed confers low risk of perinatal 9 
and vertical transmission when a face mask is worn and proper hygiene is observed58. 10 
Because of these clinical implications and the potential impact on maternal-neonate 11 
interaction, this area requires urgent investigation.                       12 
A large cohort study identified patient and surgical factors associated with 30-day 13 
mortality33. This multi-centre study is easily the largest study of postoperative 14 
outcomes in patients with COVID-19 and because of the size and quality of the 15 
analysis, it is the only study from which we can make strong conclusions33. 16 
Consequently, future studies should consider longer-term reporting of health 17 
outcomes.    18 
Previous studies found low mortality rates (1%) and requirement for respiratory 19 
support (10%) amongst pregnant women with COVID-19, as well as low neonatal 20 
transmission (5%), which our study supported59, 60. However, the duration of 21 
operation, oxygen therapy and length of hospital stay were significantly longer in 22 
suspected or confirmed patients than negative patients. An optimal approach to 23 
perioperative management in COVID-19 patients including appropriate use of 24 
anaesthetics and analgesics needs to be determined in future studies.  25 
 26 
Strengths and Limitations 27 
A major strength of the rapid review approach is the ability to quickly synthesise 28 
relevant original articles and identify current perioperative practices that are 29 































































   
associated with favourable postoperative outcomes. This has already enabled us to 1 
make early clinical recommendations (Box 2) on the perioperative management of 2 
COVID-19 to the Scottish Government, via the Scottish Intercollegiate Guidelines 3 
Network (SIGN), which can be disseminated to policymakers and HCWs and inform 4 
future perioperative practice (Roberta James, SIGN Programme Lead, personal 5 
communication, 2020). Because COVID-19 is a new and developing disease, hospital 6 
departments are having to adapt quickly to ensure optimum care and they rely on 7 
quick and accurate clinical guidance on how to provide this. However, many hospitals 8 
are not set up to conduct rapid research involving data collection, particularly during 9 
a global pandemic, and consequently there are gaps in reporting that this review has 10 
identified. A possible solution to this is to implement electronic health (eHealth) 11 
recording of patient data to ensure automated availability of relevant items of 12 
interest.    13 
Converse to the rapid synthesis of the current literature, the short period of time that 14 
COVID-19 has been in existence, relative to other infectious diseases, means that 15 
there has not been enough time for many large and comprehensive cohort studies to 16 
be published and therefore the majority of studies included in this review are case 17 
reports and series. This means that the clinical implications of these studies should 18 
be treated with caution until further robust studies are published, preferably in the 19 
form of RCTs such as the Randomised Evaluation Of COVID-19 Therapy (RECOVERY) 20 
Trial (https://www.recoverytrial.net/)61.   21 
The rapid nature of this review means that more recently published articles may have 22 
been missed, though we mitigated this risk by conducting a further (targeted) 23 
literature search prior to submission. Excluding those not in English is pertinent given 24 
the global status of the COVID-19 pandemic. We also had to exclude 2 studies from 25 
Tongji Hospital in Wuhan as some of the participants were also included in the cohort 26 
study for this paper13, 14.  27 
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Conclusions 1 
From this rapid literature review and cohort study, we can make early clinical and 2 
research recommendations around the perioperative management of patients with 3 
suspected or confirmed COVID-19. These are presented in Box 2 and include timing 4 
of COVID-19 testing prior to surgery, more detailed reporting of patients’ and HCWs’ 5 
use of PPE, more detailed reporting of the perioperative use of anaesthesia and 6 
analgesia, and research into the longer term consequences of COVID-19. Together it 7 
is anticipated that these recommendations will contribute to improved postoperative 8 
outcomes for both patients with COVID-19 and HCWs treating those patients.  9 
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Table 1 – Inclusion and exclusion criteria for studies in the review 
Inclusion Criteria Exclusion Criteria 
1. Patients with confirmed or suspected COVID-19 who have 
undergone surgery or healthcare workers who have treated 
surgical patients with confirmed or suspected COVID-19 
1. Unpublished studies, conference abstracts and research 
theses or dissertations 
2. Observational studies including case reports, case series, 
case-control, cross-sectional, cohort and randomised control 
trials. 
2. Studies that do not provide any perioperative management 
details (defined as the time from when the decision to 
operate was made to 24 hours after surgery). 
3. Written in English  3. Studies where the patients are not suspected of or 
confirmed as having COVID-19 during surgery  
 4. Studies that do not report patients that have undergone 
surgery separately from those that have not undergone 
surgery.    
 5. Studies reporting surgery only conducted to treat COVID-19 
 6. Studies
13, 14 that included participants that have also been 
included in the cohort study of this paper  
COVID-19, Coronavirus disease 2019 































































   




Country Study Design Surgery 
Method of 
Suspecting/Diagnosing 







18/04/2020 Peru Case report Caesarean section 
Nasopharyngeal RT-PCR, CT 
scan 
1 22 (61%) 
Catellani et 
al.17  
30/04/2020 Italy Case series Orthopaedic 
Oropharyngeal RT-PCR, 







14/04/2020 Iran Cross-sectional 
5 Orthopaedic, 1 
abdominal 







16/03/2020 China Case series Caesarean section Nasal RT-PCR, chest CT Scan 17 22 (61%) 
Doglietto et 
al.20 
12/06/2020 Italy Cohort 
22 Orthopaedic, 7 
vascular, 6 
neurological, 5 
general, 1 thoracic  
Nasopharyngeal RT-PCR, 
chest CT scan, chest 
radiography 
41 26 (76%) 
Dong et 
al.21 
26/03/2020 China Case report Caesarean section 
Nasopharyngeal RT-PCR, 
chest CT scan 
1 18 (50%) 
Du et al.22 19/05/2020 China Case report Caesarean section Pharyngeal RT-PCR, CT scan 1 18 (50%) 
Ferrazzi et 27/04/2020 Italy Case series Caesarean section Throat swab RT-PCR 42 (18 19 (52%) 































































   




19/04/2020 USA Case report Cardiothoracic 
CT scan (preoperatively), 
RT-PCT (postoperatively, not 
explicitly stated) 
1 25 (69%) 
Gao et al.25 18/04/2020 China Case series Abdominal 




4 17 (47%) 
Gidlöf et 
al.26 
06/04/2020 Sweden Case report Caesarean section Nasopharyngeal RNA test 1 15 (41%) 
He et al.27 21/03/2020 China Case series Cardiothoracic CT scan and clinical symptoms 4 13 (36%) 
Lee et al.28 31/03/2020 
Republic 
of Korea 
Case report Caesarean section 
Sputum and nasopharyngeal 
RT-PCR, chest CT-Scan and 
chest radiography 
1 21 (58%) 




China Case report Caesarean section 
RT-PCR (not explicitly stated) 
of sputum sample 
1 20 (55%) 
Lu et al.30 24/04/2020 China Case report Caesarean section 
Throat swab RT-PCR, chest 
CT-scan 
1 24 (66%) 
Lyra et al.31 20/04/2020 Portugal Case report Caesarean section 
Nasopharyngeal and 
oropharyngeal RT-PCR 
1 18 (50%) 
Mi et al.32 09/06/2020 China Case series Not reported Not reported 28 7 (19%) 














































































vascular, 40 head 
and neck, 39 
neurosurgery, 37 
urological, 57 other 
and 36 missing 
Nasal swab or 
bronchoalveolar lavage 
RT-PCR, relevant clinical 
symptoms (including cough, 
fever or myalgia), or 
radiological findings (thorax 
CT) 
1128 33 (97%) 
Song et al.34 26/02/2020 China Case report Caesarean section 
Throat and faecal RT-PCR, 
chest CT scan 
1 22 (61%) 
Sun et al.35 28/04/2020 China Case series Caesarean section 
Pharyngeal, laryngeal, throat 
and tracheal tube tip RT-PCR 
3 18 (50%) 
Wang et 
al.36 
28/02/2020 China Case report Caesarean section 
Throat s ab RT-PCR, chest CT 
scan 
1 21 (58%) 
Xia et al.37 17/03/2020 China Case report Caesarean section 
Oropharyngeal RT-PCR, chest 
CT-scan 
1 14 (38%) 
Zeng et al.38 26/03/2020 China Case series Caesarean section 
Symptoms, chest CT scan and 
RT-PCR 
6 9 (25%) 
Zhang et 
al.39 
08/04/2020 China Case series Caesarean section 
Suspected: Abnormal CT scan 
(ground-glass opacity and 
4 17 (47%) 































































   
bilateral patchy shadowing), 
coupled with typical clinical 
symptoms (fever, cough, 
headache, sore throat, 
shortness of breath), sputum. 
Confirmed: Nasopharyngeal 
RT-PCR 
Zhao et al.40 18/03/2020 China Clinical study 
10 abdominal, 2 




neurosurgery and 6 
other 
Laboratory, imaging (CT-scan) 
and clinical findings (body 
temperature) 
37 10 (29%) 
Zhong et 
al.41 




Radiology for inclusion in 
study, confirmation through 
throat swab RT-PCR 
49 26 (72%) 
CARE, CAse REport; CT, computed tomography; RNA, ribonucleic acid; RT-PCR, reverse transcriptase-polymerase chain reaction; STROBE, 
Strengthening The Reporting of Observational Studies in Epidemiology; UK, United Kingdom; USA, United States of America. 
*Details of the STROBE and CARE scores are provided in the methods section 































































   
Table 3 – Perioperative management details of patients in the rapid review 







































13 Orthopaedic Not 
reported 



















Unclear Unclear Unclear Unclear Not reported Not 
reported 


















Not reported Epidural 
anaesthesia 
- Mean: 








































































































Not reported Not reported Not 
reported 







































































Not reported Yes N95 mask Not reported Not 
reported 
Not reported Not reported Not 
reported 
Du et al.22 1 Caesarean 
section 












Yes More strict PPE 
than just surgical 
masks 





Not reported Not 
reported 






Yes N95 masks with 













Not reported Not reported Not 
reported 









































































Not reported Not 
reported 














Not reported Not reported ~200ml 
He et al.27 4 
Cardiothoracic 








Not reported Not reported Not 
reported 
Lee et al.28 1 Caesarean 
section 















Phenylephrine 400 cc 































































   
respirator 
Li et al.29 1 Caesarean 
section 
Yes Protective suit Yes Protective 
suit 
Not reported Not 
reported 
Not reported Not reported Not 
reported 
Lu et al.30 1 Caesarean 
section 
Yes Level 3 (gown, 














Not reported Not reported ~200ml 
Lyra et al.31 1 Caesarean 
section 








Not reported Not reported Not 
reported 
Mi et al.32 Not reported Not 
reported 




21 Spinal, 3 





















Not reported Not reported Not 
reported 








































































45 vascular, 40 




57 other and 
36 missing 










Song et 1 Caesarean Unclear Unclear Not Not Combined Not Tramadol Yes 300ml 































































   




Sun et al.35 3 Caesarean 
sections 
Yes Full (N95 mask, 






























Not reported Not reported 200ml 
Xia et al.37 1 Caesarean 
section 
Yes Third-level 
measure - N95 










1% ropivacaine Intravenous 
methoxamine 
~300ml 














































































Zeng et al.38 6 Caesarean 
sections 
Yes Protective suits 
and double 
masks 
Yes 6 masks Not reported Not 
reported 
Not reported Not reported Not 
reported 






































































Not reported Yes 1 Level 2, 
3 level 3 
Not reported Not 
reported 




































Not reported Not reported Not 
reported 























































































Not reported Not 
reported 
BSL, biosafety level; cc, cubic centimeter; HCW, health care worker; ml, millilitre; PPE, personal protective equipment; SD, standard deviation;  































































   
Box 1 – The National Health Commission of China’s diagnostic criteria for suspected cases of COVID-19 (seventh edition). 
A case that has any one condition of epidemiological history and any 2 clinical manifestations is considered as a suspected case. If there is no clear 
epidemiological history, then suspected cases need all 3 clinical manifestations. 
A. Epidemiological history 
1. History of residence or travel in Wuhan and its surrounding areas, or in other communities with cases reported within 2 weeks prior to the 
onset of the disease;  
2. History of contact with SARS-CoV-2 infected patients (positive results of nucleic acid test) within 2 weeks prior to the onset of the disease;  
3. History of contact with patients with fever and/or respiratory symptoms who are from Wuhan and its surrounding areas, or from other 
communities with cases reported within 2 weeks prior to the onset of the disease;  
4. Cluster of infections: 2 or more cases with fever and/or respiratory symptoms occurred in a small area such as home, office, and school 
class within 2 weeks prior to the onset of the disease. 
  
B. Clinical manifestations 
1. Fever and/or respiratory symptoms;  
2. Imaging features of COVID-19: multiple patchy shadows and interstitial changes in the early phase, and then multiple ground-glass 
opacities, infiltration shadows or even consolidation in advanced-phase;  
3. Normal or decreased leucocyte and lymphocyte count in the early stage of disease. 
 































































   
Box 2 – Clinical recommendations for the perioperative management of people with suspected or confirmed COVID-19 and suggestions for further research 
A. Clinical Recommendations 
During the perioperative period, when COVID-19 is suspected or confirmed: 
1. Testing for COVID-19 should be conducted preoperatively. During a pandemic or local outbreak, all patients should be tested.   
2. RT-PCR and chest CT scans (along with relevant clinical signs) should be conducted together to confirm COVID-19 diagnosis and reducing 
waiting times.  
3. Surgeries should be conducted in negative pressure operating rooms where possible, with HCWs using Level 3 PPE and patients wearing 
face masks, if practical, until further evidence is available. During a pandemic or local outbreak all HCWs should use Level 3 PPE for 
surgeries involving untested patients.  
4. Clinicians should consider relevant risk factors of increased mortality in COVID-19 patients including male gender, age >70 years, poor 
preoperative condition, malignancy and the urgency and extent of surgery before deciding whether to conduct surgery. 
5. Strategies should be implemented to reduce the risk of postoperative respiratory complications and associated mortality (e.g. use of 
regional anaesthesia over general anaesthesia and postponing surgery for patients with correctable pathophysiology).  
6. Clinical management should take account of the potential need for prolonged hospital stay, particularly in high risk groups.  
7. Clinicians should consider the isolation of neonates immediately after birth if the mother is suspected or confirmed as having COVID-19.  
 
B. Research recommendations 
1. Optimal approach to perioperative diagnosing of COVID-19 needs to be determined, taking into account false-negative rate of RT-PCR 
tests. 
2. There should be routine recording and reporting of specific perioperative management approaches, when COVID-19 is suspected or 
confirmed, including anaesthetics/analgesics used, to allow understanding of their relationships with postoperative outcomes.  
3. Individual studies should provide more detailed reporting on the duration of PPE use during the perioperative period, by HCWs and 
patients, when COVID-19 is suspected or confirmed, and whether any changes should be made for specific procedures (e.g. 
intubation/extubation).  
4. Current and future studies should record and report long term outcomes of surgery in suspected or confirmed COVID-19 for patients and 
healthcare workers. 
5. The length of time following COVID-19 resolution before a patient can undergo surgery, without increased risk, needs to be established.    































































Figure 1. PRISMA flow diagram for the identification and screening of articles for inclusion in the review 
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